ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OSE OSE Immunotherapeutics

6.24
0.60 (10.64%)
May 02 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
OSE Immunotherapeutics OSE Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
0.60 10.64% 6.24 11:40:00
Open Price Low Price High Price Close Price Prev Close
5.65 5.65 6.67 6.24 5.64
more quote information »

Recent News

Date Time Source Heading
5/02/202410:07IHNWFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
5/02/202412:00GLOBEMise à disposition du Document d’Enregistrement Universel ..
4/16/202412:00GLOBEOSE Immunotherapeutics’ Global License to Develop a Novel..
4/10/202412:00GLOBEOSE Immunotherapeutics reçoit un financement public de 8,4..
4/03/202412:00GLOBEInformations relatives au nombre total de droits de vote et..
4/02/202401:30GLOBEOSE Immunotherapeutics Announces Peer-Reviewed Publication..
3/27/202413:00GLOBEOSE Immunotherapeutics publie ses résultats financiers..
3/18/202402:30BWOSE Immunotherapeutics annonce la fin du recrutement dans..
3/01/202412:00BWOSE Immunotherapeutics : Informations relatives au nombre..
2/28/202401:45BWOSE Immunotherapeutics to Host a Live Webcast to Discuss..
2/28/202401:30BWAbbVie et OSE Immunotherapeutics annoncent un partenariat..
2/26/202412:00BWOSE Immunotherapeutics Provides Update on Clinical Results..
2/02/202412:00BWOSE Immunotherapeutics : Informations relatives au nombre..
1/19/202401:30BWOSE Immunotherapeutics Highlights Clinical Portfolio..
1/05/202412:00BWOSE Immunotherapeutics : Informations relatives au nombre..
12/11/202301:30BWOSE Immunotherapeutics and Nantes University Hospital..
12/05/202312:00BWOSE Immunotherapeutics : Informations relatives au nombre..
11/21/202312:00BWOSE Immunotherapeutics Announces a Collaboration Agreement..
11/06/202312:00BWOSE Immunotherapeutics : Informations relatives au nombre..
10/23/202312:00BWOSE Immunotherapeutics Announces First Clinical Results for..
10/16/202301:30BWOSE Immunotherapeutics Presents First Positive Clinical..
10/05/202312:00BWOSE Immunotherapeutics : Informations relatives au nombre..
9/27/202312:03BWOSE Immunotherapeutics Announces H1 2023 Results and..
9/20/202301:30BWOSE Immunotherapeutics Updates on its Research Programs in..
9/11/202312:00BWOSE Immunotherapeutics Announces: Positive Phase 3 Data from..
9/04/202312:00BWOSE Immunotherapeutics : Informations relatives au nombre..
8/01/202301:30BWOSE Immunotherapeutics annonce une nouvelle aide publique..
7/19/202312:00BWOSE Immunotherapeutics Announces Publication in Frontiers in..
7/11/202312:00BWOSE Immunotherapeutics and Nantes University Hospital..
7/10/202312:00BWOSE Immunotherapeutics : Informations relatives au nombre..
7/06/202301:30BWOSE Immunotherapeutics Announces for Lusvertikimab, its..
7/04/202312:00BWOSE Immunotherapeutics Announces New US Patent Granted for..
6/22/202312:00BWOSE Immunotherapeutics Reports on its 2023 Combined General..
6/20/202312:00BWOSE Immunotherapeutics reçoit un financement de 1,5 M€ de..
6/15/202301:30BWOSE Immunotherapeutics Presents Update on BiCKI®IL-7, CLEC-1..
6/12/202312:00BWOSE Immunotherapeutics : Informations relatives au nombre..
6/06/202301:30BWOSE Immunotherapeutics présente des abstracts cliniques sur..
6/01/202312:00BWOSE Immunotherapeutics SA : Mise à disposition des documents..
5/31/202312:00BWOSE Immunotherapeutics’ Board of Directors Proposes the..
5/12/202312:15BWOSE Immunotherapeutics : Informations relatives au nombre..
5/12/202312:00BWOSE Immunotherapeutics to Continue the Clinical Development..

Your Recent History

Delayed Upgrade Clock